US District Judge Refuses Motion to Drop Eli Lilly Whistleblower Lawsuit

Eli Lilly’s motion to drop a 2014 whistleblower lawsuit surrounding claims it misled the Centers for Medicare and Medicaid Services (CMS) has been denied by US District Court Judge Harry Leinenweber. The 2014 case, which alleges that the drugmaker lied about prices it charged distributors, will now go to a jury trial. For Medicaid to cover a drug, manufacturers must pay a rebate to state and federal governments to offset costs.

According to Fraiser Kansteiner of Fierce Pharma, “The rebates are calculated using a so-called average manufacturer’s price (AMP), which is defined as the “average unit price paid to the manufacturer for the drug in the [United] States by wholesalers for drugs distributed to the retail pharmacy class of trade,” Leinenweber explained in a new order filed Monday in the Eastern Illinois U.S. District Court.”

To learn more about the case, click here.

(Source: Fierce Pharma, March 1^st, 2022)